DrugPatentWatch Database Preview
Ferrer Internacional Company Profile
What is the competitive landscape for FERRER INTERNACIONAL, and when can generic versions of FERRER INTERNACIONAL drugs launch?
FERRER INTERNACIONAL has one approved drug.
There are three US patents protecting FERRER INTERNACIONAL drugs.
There are forty-two patent family members on FERRER INTERNACIONAL drugs in twenty-three countries and two supplementary protection certificates in two countries.
Summary for Ferrer Internacional
| International Patents: | 42 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ferrer Internacional
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 6,335,447 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,399,014 | ➤ Sign Up | ➤ Sign Up | ||||
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,180,200 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Ferrer Internacional Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Portugal | 1070713 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 9951588 | ➤ Sign Up |
| Russian Federation | 2478367 | ➤ Sign Up |
| Australia | 2009305360 | ➤ Sign Up |
| European Patent Office | 2570117 | ➤ Sign Up |
| South Korea | 20160025034 | ➤ Sign Up |
| Canada | 2327328 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Ferrer Internacional Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017000073 | Germany | ➤ Sign Up | PRODUCT NAME: OZENOXACIN; NAT. REGISTRATION NO/DATE: 97303.00.00 20170803; FIRST REGISTRATION: BELGIEN BE509591 20170517 |
| 0884 | Netherlands | ➤ Sign Up | PRODUCT NAME: OZENOXACIN; REGISTRATION NO/DATE: ES/H/414/1/DC 20170519 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
